The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

doi:10.1182/blood-2021-150523

	The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma
	Ding, Kaiyang 1; Shi, Xiao 2; Yang, Haiyan 3; Cao, Lei 2; Zhao, Xiaoli 2; Liu, Hailing 2; Wu, Wei 2; Zhang, Xiaoyan 2; Wang, Li 2; Xu, Wei 2
刊名	BLOOD
	2021-11-23
卷号	138
ISSN号	0006-4971
DOI	10.1182/blood-2021-150523
WOS研究方向	Hematology
语种	英语
出版者	AMER SOC HEMATOLOGY
WOS记录号	WOS:000736413901190
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/131852]
专题	中国科学院合肥物质科学研究院
作者单位	1.USTC, Affiliated Hosp 1, Dept Hematol, Anhui Prov Hosp, Hefei, Peoples R China 2.Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China 4.Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
推荐引用方式 GB/T 7714	Ding, Kaiyang,Shi, Xiao,Yang, Haiyan,et al. The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma[J]. BLOOD,2021,138.
APA	Ding, Kaiyang.,Shi, Xiao.,Yang, Haiyan.,Cao, Lei.,Zhao, Xiaoli.,...&Fan, Lei.(2021).The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma.BLOOD,138.
MLA	Ding, Kaiyang,et al."The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma".BLOOD 138(2021).